Perrigo | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 16.59B 5.96B 2024-12
Abbott USD 9.06B 298M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Dr.Reddys Laboratories INR 64.87B 1.28B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
J&J USD 18.63B 500M 2024-12
Merck USD 11.33B 1.4B 2024-12
Nestle CHF 39.04B 20.32B 2024-12
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Reckitt Benckiser GBP 6.26B 3.51B 2024-12
Sanofi EUR 10.07B 969M 2024-09
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Xeris Pharmaceuticals USD 67.16M 10.91M 2024-09
Zoetis USD 1.59B 71M 2024-12



Perrigo Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.